Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Bupropion inhibits noradrenaline and dopamine reuptake, whereas naltrexone is an opioid antagonist of the mesolimbic reward pathway, reducing rewards/pleasure-based or hedonic hunger
Over 12 years, most people maintain a loss of about 1015% of their starting weight if they keep up with treatment and lifestyle changes
59% Increased sleep Within 130 minutes of administration 97% Relief of symptoms Opioid withdrawal (107 patients) 86% Pain reduction Patients with chronic pain (6/7) Dog of DL50 Security Profile No lethal dose ever determined 9 amino acids Nonapeptide WAGGDASGE Sequence How does the DSIP work
For people comfortable with self-injection and who value the efficiency of virtual care, this model removes many traditional barriers to accessing obesity medicine treatment
